Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 5
1986 6
1987 3
1988 5
1989 4
1990 10
1991 7
1992 11
1993 4
1994 6
1995 7
1996 7
1997 7
1998 5
1999 8
2000 9
2001 14
2002 13
2003 16
2004 13
2005 12
2006 11
2007 12
2008 18
2009 17
2010 23
2011 29
2012 23
2013 17
2014 16
2015 20
2016 15
2017 30
2018 21
2019 25
2020 18
2021 23
Text availability
Article attribute
Article type
Publication date

Search Results

453 results
Results by year
Filters applied: . Clear all
Page 1
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial.
Cremolini C, Rossini D, Dell'Aquila E, Lonardi S, Conca E, Del Re M, Busico A, Pietrantonio F, Danesi R, Aprile G, Tamburini E, Barone C, Masi G, Pantano F, Pucci F, Corsi DC, Pella N, Bergamo F, Rofi E, Barbara C, Falcone A, Santini D. Cremolini C, et al. Among authors: danesi r. JAMA Oncol. 2019 Mar 1;5(3):343-350. doi: 10.1001/jamaoncol.2018.5080. JAMA Oncol. 2019. PMID: 30476968 Free PMC article. Clinical Trial.
Understanding EGFR heterogeneity in lung cancer.
Passaro A, Malapelle U, Del Re M, Attili I, Russo A, Guerini-Rocco E, Fumagalli C, Pisapia P, Pepe F, De Luca C, Cucchiara F, Troncone G, Danesi R, Spaggiari L, De Marinis F, Rolfo C. Passaro A, et al. Among authors: danesi r. ESMO Open. 2020 Oct;5(5):e000919. doi: 10.1136/esmoopen-2020-000919. ESMO Open. 2020. PMID: 33067323 Free PMC article. Review.
Clinical pharmacology of intravitreal anti-VEGF drugs.
Fogli S, Del Re M, Rofi E, Posarelli C, Figus M, Danesi R. Fogli S, et al. Among authors: danesi r. Eye (Lond). 2018 Jun;32(6):1010-1020. doi: 10.1038/s41433-018-0021-7. Epub 2018 Feb 5. Eye (Lond). 2018. PMID: 29398697 Free PMC article. Review.
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC.
Del Re M, Cucchiara F, Rofi E, Fontanelli L, Petrini I, Gri N, Pasquini G, Rizzo M, Gabelloni M, Belluomini L, Crucitta S, Ciampi R, Frassoldati A, Neri E, Porta C, Danesi R. Del Re M, et al. Among authors: danesi r. Cancer Immunol Immunother. 2021 Jun;70(6):1667-1678. doi: 10.1007/s00262-020-02810-6. Epub 2020 Dec 14. Cancer Immunol Immunother. 2021. PMID: 33315149 Free PMC article.
453 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page